CE vs ISPC
Celanese Corporation (CE) versus iSpecimen Inc (ISPC) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
iSpecimen Inc (ISPC) is a diagnostics & research company listed on US.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
Latest reported ISPC revenue for 2024-12-31 was $9.3M. Net income was -$12.5M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ISPC currently screens at market cap $4.4M.
CE currently screens at market cap $5.92B. ISPC currently screens at market cap $4.4M.
Not investment advice. Open the CE and ISPC stock pages for the full models.
Not investment advice.